TY - JOUR AU - Heller, S. PY - 2004 DA - 2004// TI - Weight gain during insulin therapy in patients with type 2 diabetes mellitus JO - Diab Res Clin Pract VL - 65S UR - https://doi.org/10.1016/j.diabres.2004.07.005 DO - 10.1016/j.diabres.2004.07.005 ID - Heller2004 ER - TY - JOUR PY - 1998 DA - 1998// TI - Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) JO - Lancet VL - 352 UR - https://doi.org/10.1016/S0140-6736(98)07019-6 DO - 10.1016/S0140-6736(98)07019-6 ID - ref2 ER - TY - JOUR AU - Rossetti, L. AU - Giaccari, A. AU - DeFronzo, R. A. PY - 1990 DA - 1990// TI - Glucose toxicity JO - Diabetes Care VL - 13 UR - https://doi.org/10.2337/diacare.13.6.610 DO - 10.2337/diacare.13.6.610 ID - Rossetti1990 ER - TY - JOUR AU - Kahn, S. E. AU - Haffner, S. M. AU - Heise, M. A. AU - Herman, W. H. AU - Holman, R. R. AU - Jones, N. P. AU - Kravitz, B. G. AU - Lachin, J. M. AU - O'Neill, M. C. AU - Zinman, B. AU - Viberti, G. PY - 2006 DA - 2006// TI - Glycemic durability of rosiglitazone, metformin or glyburide monotherapy JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa066224 DO - 10.1056/NEJMoa066224 ID - Kahn2006 ER - TY - JOUR AU - Lincoff AM Wolski, K. AU - Nicholls, S. J. AU - Nissen, S. E. PY - 2007 DA - 2007// TI - Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus JO - JAMA VL - 12; 298 UR - https://doi.org/10.1001/jama.298.10.1180 DO - 10.1001/jama.298.10.1180 ID - Lincoff AM Wolski2007 ER - TY - JOUR AU - Holden, S. E. AU - Currie, C. J. PY - 2012 DA - 2012// TI - Dogenous hyperinsulinaemia and exogenous insulin: a common theme between atherosclerosis, increased cancer risk and other morbidities JO - Atherosclerosis VL - 222 UR - https://doi.org/10.1016/j.atherosclerosis.2012.01.052 DO - 10.1016/j.atherosclerosis.2012.01.052 ID - Holden2012 ER - TY - JOUR AU - van Dieren, S. 1. AU - Czernichow, S. AU - Chalmers, J. AU - Kengne, A. P. AU - de Galan, B. E. AU - Poulter, N. AU - Woodward, M. AU - Beulens, J. W. AU - Grobbee, D. E. AU - van der Schouw, Y. T. AU - Zoungas, S. PY - 2012 DA - 2012// TI - Weight changes and their predictors amongst 11140 patients with type 2 diabetes in the ADVANCE trial JO - Diabetes Obes Metab VL - 14 UR - https://doi.org/10.1111/j.1463-1326.2012.01556.x DO - 10.1111/j.1463-1326.2012.01556.x ID - van Dieren2012 ER - TY - JOUR AU - Inukai, K. AU - Watanabe, M. AU - Nakashima, Y. AU - Takata, N. AU - Isoyama, A. AU - Sawa, T. AU - Kurihara, S. AU - Awata, T. AU - Katayama, S. PY - 2005 DA - 2005// TI - Glimepiride enhances intrinsic peroxisome proliferator-activated receptor-gamma activity in 3T3-L1 adipocytes JO - Biochem Biophys Res Commun VL - 328 UR - https://doi.org/10.1016/j.bbrc.2004.12.190 DO - 10.1016/j.bbrc.2004.12.190 ID - Inukai2005 ER - TY - JOUR AU - Weyer, C. AU - Funahashi, T. AU - Tanaka, S. AU - Hotta, K. AU - Matsuzawa, Y. AU - Pratley, R. E. AU - Tataranni, P. A. PY - 2001 DA - 2001// TI - Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia JO - J Clin Endocrinol Metab VL - 86 UR - https://doi.org/10.1210/jcem.86.5.7463 DO - 10.1210/jcem.86.5.7463 ID - Weyer2001 ER - TY - JOUR AU - Waki, H. AU - Yamauchi, T. AU - Kamon, J. AU - Ito, Y. AU - Uchida, S. AU - Kita, S. AU - Hara, K. AU - Hada, Y. AU - Vasseur, F. AU - Froguel, P. AU - Kimura, S. AU - Nagai, R. AU - Kadowaki, T. PY - 2003 DA - 2003// TI - Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M300365200 DO - 10.1074/jbc.M300365200 ID - Waki2003 ER - TY - JOUR AU - Kanda, Y. AU - Matsuda, M. AU - Tawaramoto, K. AU - Kawasaki, F. AU - Hashiramoto, M. AU - Matsuki, M. AU - Kaku, K. PY - 2008 DA - 2008// TI - Effects of sulfonylurea drugs on adiponectin production from 3 T3-L1 adipocytes: implication of different mechanism from pioglitazone JO - Diabetes Res Clin Pract VL - 81 UR - https://doi.org/10.1016/j.diabres.2008.01.031 DO - 10.1016/j.diabres.2008.01.031 ID - Kanda2008 ER - TY - JOUR AU - Tsunekawa, T. AU - Hayashi, T. AU - Suzuki, Y. AU - Matsui-Hirai, H. AU - Kano, H. AU - Fukatsu, A. AU - Nomura, N. AU - Miyazaki, A. AU - Iguchi, A. PY - 2003 DA - 2003// TI - Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects JO - Diabetes Care VL - 26 UR - https://doi.org/10.2337/diacare.26.2.285 DO - 10.2337/diacare.26.2.285 ID - Tsunekawa2003 ER - TY - JOUR AU - Nagasaka, S. AU - Taniguchi, A. AU - Aiso, Y. AU - Yatagai, T. AU - Nakamura, T. AU - Nakai, Y. AU - Fukushima, M. AU - Kuroe, A. AU - Ishibashi, S. PY - 2003 DA - 2003// TI - Effect of glimepiride on serum adiponectin level in subjects with type 2 diabetes JO - Diabetes Care VL - 26 UR - https://doi.org/10.2337/diacare.26.7.2215 DO - 10.2337/diacare.26.7.2215 ID - Nagasaka2003 ER - TY - JOUR AU - Fukuen, S. AU - Iwaki, M. AU - Yasui, A. AU - Makishima, M. AU - Matsuda, M. AU - Shimomura, I. PY - 2005 DA - 2005// TI - Sulfonylurea agents exhibit peroxisome proliferator-activated receptor gamma agonistic activity JO - J Biol Chem VL - 280 UR - https://doi.org/10.1074/jbc.M412113200 DO - 10.1074/jbc.M412113200 ID - Fukuen2005 ER - TY - JOUR AU - Liu, M. AU - Liu, F. PY - 2006 DA - 2006// TI - Regulation of adiponectin multimerization, signaling and function JO - J Clin Invest VL - 116 UR - https://doi.org/10.1172/JCI29126 DO - 10.1172/JCI29126 ID - Liu2006 ER - TY - JOUR AU - Aso, Y. AU - Hara, K. AU - Ozeki, N. AU - Yatsuka, C. AU - Nakano, T. AU - Matsumoto, S. AU - Suetsugu, M. AU - Nakamachi, T. AU - Takebayashi, K. AU - Haruki, K. AU - Inukai, T. PY - 2009 DA - 2009// TI - Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes JO - Diabetes Res Clin Pract VL - 85 UR - https://doi.org/10.1016/j.diabres.2009.05.015 DO - 10.1016/j.diabres.2009.05.015 ID - Aso2009 ER - TY - JOUR AU - Aso, Y. AU - Yamamoto, R. AU - Suetsugu, M. AU - Matsumoto, S. AU - Wakabayashi, S. AU - Matsutomo, R. AU - Takebayashi, K. AU - Inukai, T. PY - 2007 DA - 2007// TI - Comparison of the effects of pioglitazone and voglibose on circulating total and high-molecular-weight adiponectin, and on two fibrinolysis inhibitors, in patients with Type 2 diabetes JO - Diabet Med VL - 24 UR - https://doi.org/10.1111/j.1464-5491.2007.02204.x DO - 10.1111/j.1464-5491.2007.02204.x ID - Aso2007 ER - TY - JOUR AU - Ose, H. 1. AU - Fukui, M. AU - Kitagawa, Y. AU - Hirata, C. AU - Ichio, N. AU - Kadono, M. AU - Mogami, S. AU - Onishi, M. AU - Ichida, Y. AU - Nakajima, T. AU - Hasegawa, G. AU - Yoshikawa, T. AU - Nakamura, N. PY - 2005 DA - 2005// TI - Efficacy of glimepiride in patients with poorly controlled insulin-treated type 2 diabetes mellitus JO - Endocr J VL - 52 UR - https://doi.org/10.1507/endocrj.52.563 DO - 10.1507/endocrj.52.563 ID - Ose2005 ER - TY - JOUR AU - Riddle, M. C. AU - Schneider, J. PY - 1998 DA - 1998// TI - The glimepiride combination group beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone JO - Diabetes Care VL - 21 UR - https://doi.org/10.2337/diacare.21.7.1052 DO - 10.2337/diacare.21.7.1052 ID - Riddle1998 ER - TY - JOUR AU - Johnson, J. L. AU - Wolf, S. L. AU - Kabadi, U. M. PY - 1996 DA - 1996// TI - Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials JO - Arch Intern Med VL - 12; 156 UR - https://doi.org/10.1001/archinte.1996.00440030049007 DO - 10.1001/archinte.1996.00440030049007 ID - Johnson1996 ER - TY - JOUR AU - Mocanu, M. M. AU - Maddock, H. L. AU - Baxter, G. F. AU - Lawrence, C. L. AU - Standen, N. B. AU - Yellon, D. M. PY - 2001 DA - 2001// TI - Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide JO - Circulation VL - 103 UR - https://doi.org/10.1161/01.CIR.103.25.3111 DO - 10.1161/01.CIR.103.25.3111 ID - Mocanu2001 ER - TY - JOUR AU - Pantalone, K. M. AU - Kattan, M. W. AU - Yu, C. AU - Wells, B. J. AU - Arrigain, S. AU - Jain, A. AU - Atreja, A. AU - Zimmerman, R. S. PY - 2010 DA - 2010// TI - The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis JO - Diabetes Care VL - 33 UR - https://doi.org/10.2337/dc10-0017 DO - 10.2337/dc10-0017 ID - Pantalone2010 ER - TY - JOUR AU - Kishida, K. AU - Funahashi, T. AU - Shimomura, I. PY - 2012 DA - 2012// TI - Clinical importance of assessment of type 2 diabetes mellitus with visceral obesity. A Japanese perspective JO - Curr Diabetes Rev VL - 8 UR - https://doi.org/10.2174/157339912799424546 DO - 10.2174/157339912799424546 ID - Kishida2012 ER - TY - JOUR AU - Okauchi, Y. AU - Kishida, K. AU - Funahashi, T. AU - Noguchi, M. AU - Ogawa, T. AU - Ryo, M. AU - Okita, K. AU - Iwahashi, H. AU - Imagawa, A. AU - Nakamura, T. AU - Matsuzawa, Y. AU - Shimomura, I. PY - 2009 DA - 2009// TI - Changes in serum adiponectin concentrations correlate with changes in BMI, waist circumference, and estimated visceral fat area in middle-aged general population JO - Diabetes Care VL - 32 UR - https://doi.org/10.2337/dc09-1130 DO - 10.2337/dc09-1130 ID - Okauchi2009 ER - TY - JOUR AU - Nagasaka, S. AU - Taniguchi, A. AU - Aiso, Y. AU - Yatagai, T. AU - Nakamura, T. AU - Nakai, Y. PY - 2003 DA - 2003// TI - Glimepiride and serum adiponectin level in type 2 diabetic subjects JO - Diabetes Care VL - 26 UR - https://doi.org/10.2337/diacare.26.12.3361 DO - 10.2337/diacare.26.12.3361 ID - Nagasaka2003 ER - TY - JOUR AU - Kadowaki, T. AU - Yamauchi, T. AU - Kubota, N. AU - Hara, K. AU - Ueki, K. AU - Tobe, K. PY - 2006 DA - 2006// TI - Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome JO - J Clin Invest VL - 116 UR - https://doi.org/10.1172/JCI29126 DO - 10.1172/JCI29126 ID - Kadowaki2006 ER - TY - JOUR AU - Yu, J. G. AU - Javorschi, S. AU - Hevener, A. L. AU - Kruszynska, Y. T. AU - Norman, R. A. AU - Sinha, M. AU - Olefsky, J. M. PY - 2002 DA - 2002// TI - The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects JO - Diabetes VL - 51 UR - https://doi.org/10.2337/diabetes.51.10.2968 DO - 10.2337/diabetes.51.10.2968 ID - Yu2002 ER - TY - JOUR AU - Davis, S. N. PY - 2004 DA - 2004// TI - The role of glimepiride in the effective management of type 2 diabetes JO - J Diabetes Complications VL - 18 UR - https://doi.org/10.1016/j.jdiacomp.2004.07.001 DO - 10.1016/j.jdiacomp.2004.07.001 ID - Davis2004 ER - TY - JOUR AU - Korytkowski, M. T. PY - 2004 DA - 2004// TI - Sulfonylurea treatment of type 2 diabetes mellitus: focus on glimepiride JO - Pharmacotherapy VL - 24 UR - https://doi.org/10.1592/phco.24.6.606.34752 DO - 10.1592/phco.24.6.606.34752 ID - Korytkowski2004 ER - TY - JOUR AU - Miettinen, O. AU - Nurminen, M. PY - 1985 DA - 1985// TI - Comparative-analysis of 2 rates JO - Stat Med VL - 4 UR - https://doi.org/10.1002/sim.4780040211 DO - 10.1002/sim.4780040211 ID - Miettinen1985 ER -